Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05188183 · ClinicalTrials.gov registry record · NA

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response

A NA study of Phantom Limb Pain, sponsored by Spaulding Rehabilitation Hospital.

Recruiting
Registry status
NA
Development phase
290
Enrollment target
1
Study location

NCT05188183 is a NA study of Phantom Limb Pain that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 290 participants, above the 98-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (196% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05188183, a NA study of Phantom Limb Pain, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.

RECRUITING
Registry status
NA
Development phase
290 participants
Enrollment target
1
Study location

Study Summary

The investigators have designed a pragmatic trial of home-based transcranial direct current stimulation (tDCS) for phantom limb pain (PLP), the PLP-EVEREST trial (PLP-EffectiVEness pRagmatic Stimulation Trial) to test a portable device that would reach underrepresented populations and would validate this therapy in a more pragmatic setting. Subjects will be randomized to home-based tDCS of the primary motor cortex (M1) with somatosensory training or usual care only (including their current pharmacological treatments, physical therapy, and occupational therapy). The investigators will therefore test the effectiveness of home-based tDCS and somatosensory training in a real-world, home-based setting. The Investigator will compare patients randomized to this combined strategy vs. usual care alone (subjects from this group will be offered combined treatment at the end of the trial). The investigators hypothesize that the combined strategy will be associated with a significantly larger Cohen's d effect size (at least 1) compared to the control group.

Conditions Studied

Interventions

  • OTHER Usual Care
  • DEVICE M1 anodal home-based tDCS
  • BEHAVIORAL Somatosensory Training

Study Locations (1)

Massachusetts

  • Spaulding Hospital Cambridge - Cambridge

Trial Details

FieldValue
Enrollment Target 290 participants
Start Date 2022-09-01
Est. Completion 2027-07-31
Phase NA

Sponsor

Spaulding Rehabilitation Hospital

101 total trials

What the Registry Record Tells You About NCT05188183

The ClinicalTrials.gov registry entry for NCT05188183 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 98-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (196% higher). The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Phantom Limb Pain appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.

NCT05188183 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05188183 about?

NCT05188183 is a clinical study titled "Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response". The investigators have designed a pragmatic trial of home-based transcranial direct current stimulation (tDCS) for phantom limb pain (PLP), the PLP-EVEREST trial (PLP-EffectiVEness pRagmatic Stimulation Trial) to test a portable device that would reach underrepresented populations and would validate...

What is the current status of trial NCT05188183?

This trial is currently recruiting. It is a NA study. The enrollment target is 290 participants. The study started on 2022-09-01. Estimated completion is 2027-07-31.

What conditions does trial NCT05188183 study?

This clinical trial studies the following conditions: Phantom Limb Pain.

What interventions are being tested in trial NCT05188183?

The interventions under investigation include: Usual Care (OTHER), M1 anodal home-based tDCS (DEVICE), Somatosensory Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05188183?

This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05188183 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.